Pennant Reports First Quarter 2025 Results

Rhea-AI Summary

Pennant Group (NASDAQ: PNTG) reported strong Q1 2025 financial results with significant growth across all segments. Total revenue increased 33.7% to $209.8 million, while net income grew 58.5% to $7.8 million. The company's Home Health and Hospice segment showed remarkable performance with revenue up 37.2% to $159.9 million. Total home health admissions increased 28.9% to 18,878, and hospice average daily census grew 28.1% to 3,794. The Senior Living Services segment also demonstrated solid growth with revenue increasing 23.6% to $50.0 million, maintaining a 78.5% occupancy rate and achieving an 11.3% increase in average monthly revenue per occupied room to $5,193. GAAP diluted EPS was $0.22, while adjusted diluted EPS reached $0.27 for the quarter.

Positive

• Total revenue increased 33.7% YoY to $209.8 million
• Net income grew 58.5% YoY to $7.8 million
• Home Health and Hospice segment revenue up 37.2% to $159.9 million
• Total home health admissions increased 28.9% YoY
• Senior Living Services revenue grew 23.6% YoY
• Average monthly revenue per occupied room increased 11.3% YoY

Negative

• None.

Insights

Healthcare Financial Analyst

Pennant reported exceptional Q1 growth with 33.7% revenue increase, 58.5% net income growth, and improved margins across all segments.

Pennant Group's Q1 2025 results demonstrate remarkable financial momentum across all business segments. Revenue surged 33.7% to $209.8 million, while net income jumped 58.5% to $7.8 million. The strengthening profit margins are particularly noteworthy, with adjusted EBITDA growing 45.9% to $16.4 million.

The Home Health and Hospice segment, which represents 76.1% of total revenue, showed the strongest performance with 37.2% revenue growth to $159.9 million. This segment's adjusted EBITDA increased by 40.6%, demonstrating excellent operational leverage. Meanwhile, the Senior Living segment, comprising 23.9% of revenue, grew by 23.6% with a 40.8% increase in adjusted EBITDA despite flat occupancy.

The company's ability to grow earnings faster than revenue points to successful scaling of operations and cost management. However, investors should note the balance sheet changes - cash decreased from $24.2 million to $5.2 million during the quarter, while the company took on $52.5 million in long-term debt. This corresponds with $50.3 million used in investing activities, indicating significant acquisition-driven growth supplementing organic performance.

Healthcare Operations Expert

Strong operational metrics across all services with impressive admission growth, census increases, and higher per-patient revenue driving exceptional results.

The operational metrics behind Pennant's financial success reveal a company firing on all cylinders. Home health admissions surged 28.9% to 18,878, while Medicare home health admissions increased 19.7%. The average Medicare revenue per episode rose 9.3% to $3,801, indicating both volume growth and improved revenue capture per patient.

On the hospice side, admissions grew 22.8% with average daily census increasing 28.1% to 3,794 patients. This significant census growth, coupled with a 1.6% increase in Medicare revenue per day, demonstrates both excellent patient acquisition and retention.

The senior living segment presents an interesting story: while occupancy remained flat at 78.5% (potentially reflecting broader industry challenges), average monthly revenue per occupied room increased 11.3% to $5,193. This suggests successful implementation of pricing strategies and potentially enhanced service offerings.

Management's comments about "ongoing investments in leadership development" correlate with these operational improvements, suggesting that organizational development is translating directly to enhanced performance metrics. The home care and other services category showed particularly dramatic growth from $4.7 million to $15.2 million, indicating successful diversification within their home-based care portfolio.

Conference Call and Webcast scheduled for tomorrow, May 7, 2025 at 10:00 am MT

EAGLE, Idaho, May 06, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.22 for the first quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.27 for the quarter⁽¹⁾.

First Quarter Highlights

• Total revenue for the first quarter was $209.8 million, an increase of $52.9 million or 33.7% over the prior year quarter;
  
  
• Net income for the first quarter was $7.8 million, an increase of $2.9 million or 58.5% over the prior year quarter;
  
  
• Adjusted net income for the first quarter was $9.6 million, an increase of $3.7 million or 61.4% over the prior year quarter;
  
  
• Consolidated Adjusted EBITDAR for the first quarter was $28.0 million, an increase of $6.6 million or 31.0% over the prior year quarter;
  
  
• Consolidated Adjusted EBITDA for the first quarter was $16.4 million, an increase of $5.1 million or 45.9% over the prior year quarter;
  
  
• Home Health and Hospice Services segment revenue for the first quarter was $159.9 million, an increase of $43.4 million or 37.2% over the prior year quarter;
  
  
• Home Health and Hospice Services segment adjusted EBITDAR from operations for the first quarter was $27.3 million, an increase of $7.7 million or 39.5% over the prior year quarter; and segment adjusted EBITDA from operations for the first quarter was $25.1 million, an increase of $7.3 million or 40.6% over the prior year quarter;
  
  
• Total home health admissions for the first quarter were 18,878, an increase of 4,229 or 28.9% over the prior year quarter; total Medicare home health admissions for the first quarter were 7,599, an increase of 1,253 or 19.7% over the prior year quarter;
  
  
• Hospice average daily census for the first quarter was 3,794, an increase of 832 or 28.1% compared to the prior year quarter;
  
  
• Senior Living Services segment revenue for the first quarter was $50.0 million, an increase of $9.5 million or 23.6% over the prior year quarter; average occupancy for the first quarter was 78.5%, which is flat with the prior year quarter, and average monthly revenue per occupied room for the first quarter was $5,193, an increase of $526 or 11.3% over the prior year quarter;
  
  
• Senior Living segment adjusted EBITDAR from operations for the first quarter was $14.4 million, an increase of $2.4 million or 20.3% over the prior year quarter; and segment adjusted EBITDA from operations for the first quarter was $4.9 million, an increase of $1.4 million or 40.8% over the prior year quarter.
  

(1	)		See "Reconciliation of GAAP to Non-GAAP Financial Information.”
(2	)		Same store senior living results is defined as all senior living communities excluding affiliate memory care units in transition, and new senior living operations acquired in 2024 or 2025.

Operating Results

“We are off to a strong start in 2025,” said Brent Guerisoli, the Company’s Chief Executive Officer. “Our ongoing investments in leadership development are fueling record operational results. We are encouraged to see positive momentum across all facets of our business, which is showing in our clinical, cultural and financial outcomes.”

“Our home health and hospice segment performance is at all time highs as we add quality acquisitions to robust organic growth,” said John Gochnour, the Company’s President and Chief Operating Officer. “Our senior living segment is anchored by solid leaders whose results continue to improve. We are pleased to begin the year with a quarter that significantly exceeded our targets and commitments across the Company.”

A discussion of the Company’s use of Non-GAAP financial measures is set forth below. A reconciliation of net income to EBITDA, adjusted EBITDAR and adjusted EBITDA, as well as a reconciliation of GAAP earnings per share, net income to adjusted net earnings per share and adjusted net income, appear in the financial data portion of this release. More complete information is contained in the Company’s Form 10-Q for the three months ended March 31, 2025, which has been filed with the SEC today and can be viewed on the Company’s website at www.pennantgroup.com.

Conference Call

A live webcast will be held tomorrow, May 7, 2025 at 10:00 a.m. Mountain time (12:00 p.m. Eastern time) to discuss Pennant’s first quarter 2025 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Pennant’s website at https://investor.pennantgroup.com. The webcast will be recorded and will be available for replay via the website.

About Pennant

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 137 home health and hospice agencies and 60 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and/or 10-K, for a more complete discussion of the risks and other factors that could affect Pennant’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Pennant does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Contact Information

Investor Relations
The Pennant Group, Inc.
(208) 506-6100
ir@pennantgroup.com

SOURCE: The Pennant Group, Inc.

THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(unaudited, in thousands, except for per-share amounts)
	Three Months Ended March 31,
		2025				2024
Revenue	$	209,842			$	156,915
Expense
Cost of services		168,745				125,995
Rent—cost of services		11,715				10,384
General and administrative expense		14,840				11,436
Depreciation and amortization		1,892				1,331
Gain on disposition of property and equipment, net		—				(755	)
Total expenses		197,192				148,391
Income from operations		12,650				8,524
Other (expense) income, net:
Other (expense) income		(69	)			85
Interest expense, net		(1,205	)			(1,792	)
Other expense, net		(1,274	)			(1,707	)
Income before provision for income taxes		11,376				6,817
Provision for income taxes		2,854				1,759
Net income		8,522				5,058
Less: Net income attributable to noncontrolling interest		747				152
Net income attributable to The Pennant Group, Inc.	$	7,775			$	4,906
Earnings per share:
Basic	$	0.23			$	0.16
Diluted	$	0.22			$	0.16
Weighted average common shares outstanding:
Basic		34,471				30,046
Diluted		35,202				30,403

THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except par value)
	March 31, 2025				December 31, 2024
Assets
Current assets:
Cash	$	5,221			$	24,246
Accounts receivable—less allowance for doubtful accounts of $373 and $232, respectively		94,992				81,302
Prepaid expenses and other current assets		23,676				17,308
Total current assets		123,889				122,856
Property and equipment, net		43,524				43,296
Operating lease right-of-use assets		278,210				270,586
Restricted and other assets		24,214				17,477
Goodwill		154,904				129,124
Other indefinite-lived intangibles		118,882				96,182
Total assets	$	743,623			$	679,521
Liabilities and equity
Current liabilities:
Accounts payable	$	18,800			$	18,737
Accrued wages and related liabilities		27,691				43,106
Operating lease liabilities—current		20,557				19,671
Other accrued liabilities		20,925				20,186
Total current liabilities		87,973				101,700
Long-term operating lease liabilities—less current portion		260,236				253,420
Deferred tax liabilities, net		2,776				1,861
Other long-term liabilities		17,112				10,575
Long-term debt		52,500				—
Total liabilities		420,597				367,556
Commitments and contingencies
Equity:
Common stock, $0.001 par value; 100,000 shares authorized; 34,736 and 34,445 shares issued and outstanding at March 31, 2025, respectively; and 34,670 and 34,373 shares issued and outstanding at December 31, 2024, respectively		35				35
Additional paid-in capital		238,630				236,091
Retained earnings		64,997				57,222
Treasury stock, at cost, 3 shares at March 31, 2025 and December 31, 2024		(65	)			(65	)
Total The Pennant Group, Inc. stockholders’ equity		303,597				293,283
Noncontrolling interest		19,429				18,682
Total equity		323,026				311,965
Total liabilities and equity	$	743,623			$	679,521

THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:
	Three Months Ended March 31,
		2025				2024
Net cash (used in) provided by operating activities	$	(21,229	)		$	545
Net cash used in investing activities		(50,301	)			(23,636	)
Net cash provided by financing activities		52,505				19,754
Net decrease in cash		(19,025	)			(3,337	)
Cash beginning of period		24,246				6,059
Cash end of period	$	5,221			$	2,722

THE PENNANT GROUP, INC.
REVENUE BY SEGMENT
(unaudited, dollars in thousands)
The following table sets forth our total revenue by segment and as a percentage of total revenue for the periods indicated:
	Three Months Ended March 31,
		2025						2024
	Revenue Dollars			Revenue Percentage			Revenue Dollars			Revenue Percentage
Home health and hospice services
Home health	$	74,118		35.3	%		$	57,212		36.5	%
Hospice		70,586		33.6				54,607		34.8
Home care and other(a)		15,166		7.2				4,671		3.0
Total home health and hospice services		159,870		76.1				116,490		74.3
Senior living services		49,972		23.9				40,425		25.7
Total revenue	$	209,842		100.0	%		$	156,915		100.0	%

(a)		Home care and other revenue is included with home health revenue in other disclosures in this press release.

THE PENNANT GROUP, INC.
SELECT PERFORMANCE INDICATORS
(unaudited, total revenue dollars in thousands)
The following table summarizes our overall home health and hospice performance indicators for the each of the dates or periods indicated:
	Three Months Ended March 31,
	2025			2024			Change			% Change
Total agency results:
Home health and hospice revenue	$	159,870		$	116,490			43,380		37.2	%
Home health services:
Total home health admissions		18,878			14,649			4,229		28.9	%
Total Medicare home health admissions		7,599			6,346			1,253		19.7	%
Average Medicare revenue per 60-day completed episode(a)	$	3,801		$	3,477		$	324		9.3	%
Hospice services:
Total hospice admissions		3,783			3,080			703		22.8	%
Average daily census		3,794			2,962			832		28.1	%
Hospice Medicare revenue per day	$	190		$	187		$	3		1.6	%

(a)		The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.

	Three Months Ended March 31,
	2025			2024			Change			% Change
Same agency(b) results:
Home health and hospice revenue	$	122,451		$	110,015		$	12,436		11.3	%
Home health services:
Total home health admissions		14,082			12,554			1,528		12.2	%
Total Medicare home health admissions		5,812			5,536			276		5.0	%
Average Medicare revenue per 60-day completed episode(a)	$	3,623		$	3,422		$	201		5.9	%
Hospice services:
Total hospice admissions		3,181			3,080			101		3.3	%
Average daily census		3,270			2,962			308		10.4	%
Hospice Medicare revenue per day	$	190		$	187		$	3		1.6	%

(a)		The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
(b)		Same agency results represent all agencies purchased or licensed prior to January 1, 2024.

The following table summarizes our senior living performance indicators for the periods indicated:

	Three Months Ended March 31,
		2025				2024			Change				% Change
Total senior living results:
Senior living revenue	$	49,972			$	40,425			$	9,547			23.6	%
Occupancy		78.5	%			78.5	%			—	%
Average monthly revenue per occupied unit	$	5,193			$	4,667			$	526			11.3	%

	Three Months Ended March 31,
		2025				2024			Change				% Change
Same store senior living(a) results:
Senior living revenue	$	43,263			$	39,739			$	3,524			8.9	%
Occupancy		79.2	%			79.4	%			(0.2)	%
Average monthly revenue per occupied unit	$	5,093			$	4,641			$	452			9.7	%

(a)		Same store senior living results is defined as all senior living communities excluding affiliate memory care units in transition, and new senior living operations acquired in 2024 or 2025.

THE PENNANT GROUP, INC.
REVENUE BY PAYOR SOURCE
(unaudited, dollars in thousands)
The following table presents our total revenue by payor source as a percentage of total revenue for the periods indicated:
		Three Months Ended March 31,
			2025						2024
		Revenue Dollars			Revenue Percentage			Revenue Dollars			Revenue Percentage
Revenue:
Medicare		$	101,125		48.2	%		$	76,981		49.1	%
Medicaid			27,338		13.0				25,066		16.0
Subtotal			128,463		61.2				102,047		65.1
Managed Care			30,714		14.6				20,122		12.8
Private and Other(a)			50,665		24.2				34,746		22.1
Total revenue		$	209,842		100.0	%		$	156,915		100.0	%

(a)

Private and other payors includes revenue from all payors generated in the Company’s home care operations and management services agreement.

THE PENNANT GROUP, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(unaudited, in thousands, except per share data)
The following table reconciles net income to Non-GAAP net income for the periods presented:
	Three Months Ended March 31,
		2025				2024
Net income attributable to The Pennant Group, Inc.	$	7,775			$	4,906
Non-GAAP adjustments
Costs at start-up operations(a)		93				80
Share-based compensation expense(b)		2,167				1,526
Acquisition related costs and credit allowances(c)		272				137
Costs associated with transitioning operations(d)		75				(573	)
Unusual, non-recurring or redundant charges(e)		51				275
Provision for income taxes on Non-GAAP adjustments(f)		(809	)			(389	)
Non-GAAP net income	$	9,624			$	5,962
Dilutive Earnings Per Share As Reported
Net Income	$	0.22			$	0.16
Average number of shares outstanding		35,202				30,403
Adjusted Diluted Earnings Per Share
Net Income	$	0.27			$	0.20
Average number of shares outstanding		35,202				30,403

(a)		Represents results related to start-up operations.
					Three Months Ended March 31,
						2025				2024
		Revenue			$	(865	)		$	(2,410	)
		Cost of services				943				2,328
		Rent				7				156
		Depreciation & amortization				8				6
		Total Non-GAAP adjustment			$	93			$	80
(b)		Represents share-based compensation expense incurred for the periods presented.
					Three Months Ended March 31,
						2025				2024
		Cost of services			$	1,195			$	762
		General and administrative				972				764
		Total Non-GAAP adjustment			$	2,167			$	1,526
(c)		Represents costs incurred to acquire an operation that are not capitalizable.

(d)		During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is converting the facility into an assisted living community. We received insurance proceeds related to the property in 2024 which were recorded as a gain on asset disposition on the consolidated statements of income.
					Three Months Ended March 31,
						2025			2024
		Cost of services				20			(628	)
		Rent				52			52
		Depreciation				3			3
		Total Non-GAAP adjustment			$	75		$	(573	)
(e)		Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
(f)		Represents an adjustment to the provision for income tax to the year-to-date effective tax rate of 26.1% and 26.0% for the three months ended March 31, 2025 and 2024, respectively. This rate excludes the tax benefit of share-based payment awards.

The table below reconciles Consolidated net income to the Consolidated Non-GAAP financial measures, Consolidated Adjusted EBITDA, and to the Non-GAAP valuation measure, Consolidated Adjusted EBITDAR, for the periods presented:

	Three Months Ended March 31,
		2025				2024
Consolidated net income	$	8,522			$	5,058
Less: Net income attributable to noncontrolling interest		747				152
Add: Provision for income taxes		2,854				1,759
Net interest expense		1,205				1,792
Depreciation and amortization		1,892				1,331
Consolidated EBITDA		13,726				9,788
Adjustments to Consolidated EBITDA
Add: Start-up operations(a)		78				(82	)
Share-based compensation expense(b)		2,167				1,526
Acquisition related costs and credit allowances(c)		272				137
Activities associated with transitioning operations(d)		20				(628	)
Unusual, non-recurring or redundant charges(e)		51				275
Rent related to items (a) and (d) above		59				208
Consolidated Adjusted EBITDA		16,373				11,224
Rent—cost of services		11,715				10,384
Rent related to items (a) and (d) above		(59	)			(208	)
Adjusted rent—cost of services		11,656				10,176
Consolidated Adjusted EBITDAR(f)	$	28,029

(a)		Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations.
(b)		Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.
(c)		Non-capitalizable costs associated with acquisitions, credit allowances, and write offs for amounts in dispute with the prior owners of certain acquired operations.
(d)		During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is converting the facility into an assisted living community. We received insurance proceeds related to the property in 2024 which were recorded as a gain on asset disposition on the consolidated statements of income.
(e)		Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
(f)		This measure is a valuation measure and is displayed thusly, it is not a performance measure as it excludes rent expense, which is a normal and recurring operating expense and, as such, does not reflect our cash requirements for leasing commitments. Our presentation of Consolidated Adjusted EBITDAR should not be construed as a financial performance measure.

The following table present certain financial information regarding our reportable segments. General and administrative expenses are not allocated to the reportable segments:

	Home Health and Hospice Services			Senior Living Services			All Other			Total
Three Months Ended March 31, 2025
Revenue	$	159,443		$	49,534		$	865		$	209,842
Segment Cost of Services	$	132,169		$	35,085
Segment Adjusted EBITDAR from Operations	$	27,274		$	14,449					$	41,723
Three Months Ended March 31, 2024
Revenue	$	114,490		$	40,015		$	2,410		$	156,915
Segment Cost of Services	$	94,940		$	28,004
Segment Adjusted EBITDAR from Operations	$	19,550		$	12,011					$	31,561

The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations:

	Three Months Ended March 31,
		2025				2024
Segment Adjusted EBITDAR from Operations(a)	$	41,723			$	31,561
Less: Unallocated corporate expenses		13,694				10,161
Less: Depreciation and amortization		1,892				1,331
Rent—cost of services		11,715				10,384
Other income		(69	)			85
Adjustments to Segment EBITDAR from Operations:
Less: Start-up operations(b)		78				(82	)
Share-based compensation expense(c)		2,167				1,526
Acquisition related costs and credit allowances(d)		272				137
Activities associated with transitioning operations(e)		20				(628	)
Unusual, non-recurring or redundant charges(f)		51				275
Add: Net income attributable to noncontrolling interest		747				152
Income from operations	$	12,650			$	8,524

(a)		Segment Adjusted EBITDAR from Operations is net income attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, unallocated corporate and administrative expenses, and, in order to view the operations’ performance on a comparable basis from period to period, certain adjustments including: (1) start-up operations, (2) share-based compensation expense, (3) acquisition related costs and credit allowances, (4) costs associated with transitioning operations, (5) unusual, non-recurring, or redundant charges, and (6) net income attributable to noncontrolling interest. “All Other” consists of revenues generated at operating locations not included in the segment financial information reviewed by the CODM. Revenue included in the “All Other” category is insignificant individually, and therefore does not constitute a reportable segment. General and administrative expenses are not allocated to the reportable segments, and are included as “Unallocated corporate expenses”, accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited.
(b)		Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations.
(c)		Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.
(d)		Non-capitalizable costs associated with acquisitions, credit allowances, and write offs for amounts in dispute with the prior owners of certain acquired operations.
(e)		During the year ended December 31, 2023, an affiliate of the Company placed its memory care units into transition and is converting the facility into an assisted living community. We received insurance proceeds related to the property in 2024 which were recorded as a gain on asset disposition on the consolidated statements of income.
(f)		Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.

The tables below reconcile Segment Adjusted EBITDAR from Operations to Segment Adjusted EBITDA from Operations for each reportable segment for the periods presented:

	Three Months Ended March 31,
	Home Health and Hospice								Senior Living
		2025				2024				2025				2024
Segment Adjusted EBITDAR from Operations	$	27,274			$	19,550			$	14,449			$	12,011
Less: Rent—cost of services		2,142				1,729				9,573				8,655
Rent related to start-up and transitioning operations		(7	)			(65	)			(52	)			(143	)
Segment Adjusted EBITDA from Operations	$	25,139			$	17,886			$	4,928			$	3,499

Discussion of Non-GAAP Financial Measures

EBITDA consists of net income before (a) interest expense, net, (b) provisions for income taxes, and (c) depreciation and amortization. Adjusted EBITDA consists of net income attributable to the Company before (a) interest expense, net (b) provisions for income taxes, (c) depreciation and amortization, (d) results related to start-up operations, including rent and excluding depreciation, interest and income taxes, (e) share-based compensation expense, (f) non-capitalizable acquisition related costs and credit allowances, (g) activities associated with transitioning operations, (h) unusual, non-recurring or redundant charges and (i) net income attributable to noncontrolling interest. Consolidated Adjusted EBITDAR is a valuation measure applicable to current periods only and consists of net income attributable to the Company before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) results related to start-up operations, excluding rent, depreciation, interest and income taxes, (f) share-based compensation expense, (g) acquisition related costs and credit allowances, (h) activities associated with transitioning operations, (i) unusual, non-recurring or redundant charges and (j) net income attributable to noncontrolling interest. The company believes that the presentation of EBITDA, adjusted EBITDA, consolidated adjusted EBITDAR, adjusted net income and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. The company believes disclosure of adjusted net income, adjusted net income per share, EBITDA, adjusted EBITDA and consolidated adjusted EBITDAR has economic substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measure provides useful information to investors, the specific manner in which management uses this measure, and some of the limitations associated with the use of this measure, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Pennant’s website at http://www.pennantgroup.com.

FAQ

What were PNTG's earnings per share in Q1 2025?

Pennant Group reported GAAP diluted earnings per share of $0.22 and adjusted diluted earnings per share of $0.27 for Q1 2025.

How much did Pennant Group's revenue grow in Q1 2025?

Pennant Group's total revenue grew by 33.7% year-over-year to $209.8 million in Q1 2025.

What was PNTG's Home Health and Hospice segment performance in Q1 2025?

The Home Health and Hospice segment revenue increased 37.2% to $159.9 million, with total home health admissions up 28.9% to 18,878 and hospice average daily census growing 28.1% to 3,794.

How did Pennant Group's Senior Living Services perform in Q1 2025?

Senior Living Services revenue increased 23.6% to $50.0 million, with 78.5% occupancy and average monthly revenue per occupied room growing 11.3% to $5,193.

What was Pennant Group's net income for Q1 2025?

Pennant Group reported net income of $7.8 million in Q1 2025, representing a 58.5% increase from the prior year quarter.